Pancreatic Cancer Research

ResearcherEli Lilly (United States)No recent work listed

Karim Adnane Benhadji

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9883-6970; OpenAlex author ID A5006585898. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: none · 2021: 1 paper

Papers 5

  1. Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer. Co-author DOI 10.1136/jitc-2020-002068↗
  2. TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer. Co-author DOI 10.1007/s00280-019-03807-4↗
  3. Population pharmacokinetics and exposure-overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cance… Last author DOI 10.1007/s00280-019-03931-1↗
  4. Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer. Co-author DOI 10.1038/s41416-018-0246-z↗
  5. Phase 1b study of galunisertib in combination with gemcitabine in Japanese patients with metastatic or locally advanced pancreatic cancer. Co-author DOI 10.1007/s00280-017-3313-x↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Davide Melisi · 4 shared papers, 2018–2021 · strength 0.34
  2. Teresa Mercade Macarulla · 4 shared papers, 2018–2021 · strength 0.34
  3. Ivelina Gueorguieva · 3 shared papers, 2018–2021 · strength 0.26
  4. Rocio García‐Carbonero · 3 shared papers, 2018–2021 · strength 0.24
  5. Josep M. Tabernero · 3 shared papers, 2018–2019 · strength 0.23
  6. Valeria Merz · 2 shared papers, 2019–2021 · strength 0.20
  7. G. Deplanque · 2 shared papers, 2018–2019 · strength 0.14
  8. Denis Pezet · 2 shared papers, 2018–2019 · strength 0.14
  9. Anna M. Varghese · 1 shared paper, 2021 · strength 0.10
  10. Do‐Youn Oh · 1 shared paper, 2021 · strength 0.10
  11. Antoine Hollebecque · 1 shared paper, 2021 · strength 0.10
  12. Emiliano Calvo · 1 shared paper, 2021 · strength 0.10
  13. Erkut Hasan Borazanci · 1 shared paper, 2021 · strength 0.10
  14. Francesca Simionato · 1 shared paper, 2019 · strength 0.08
  15. Masafumi Ikeda · 1 shared paper, 2017 · strength 0.07
  16. Hideki Ueno · 1 shared paper, 2017 · strength 0.07
  17. Helmut Oettle · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.